This protocol addresses adults aged 16 years and older presenting with epilepsy with myoclonic-atonic seizures — a seizure type characterised by a myoclonic seizure followed by an atonic seizure. This specific age group and seizure pattern defines the clinical population for this management approach.
The primary clinical objective is reduction or elimination of seizures, with the overarching goal of achieving seizure freedom.
Management of this condition may involve antiepileptic drug therapy combining more than one indicated agent — the full selection, sequencing, and individualised algorithm are detailed in the complete protocol.
Full regimen, agent selection, and clinical algorithm available via the link below.